ArticleJournal of nanobiotechnology2026
Polyphenolic nanodot-integrated spindle nanoplatform heals oral mucositis via microbiota restoration and glycolysis inhibition.
Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Oral mucositis (OM) is a debilitating complication occuring in most patients receiving chemotherapy. Through correlation analysis of oral microbiota sequencing data with host metabolomics data, we confirmed that disruption of the oral microbiota (dysbiosis) could lead to changes in metabolic activity in mucosal tissues, characterized by increased glycolysis in epithelial cells. Here, on the basis of the three-level microbiota-microenvironment-host metabolism regulatory network of in OM, we propose an integrated biofunctional nanoplatform (CP@ZS-NDs) that consists of a spindle-shaped zinc silicate core with polyphenol chlorogenic acid nanodots adsorbed on its outer surface, is delivered via a gel delivery system and has wet tissue surface adhesion and antioxidant capabilities. CP@ZS-NDs influence carbohydrate metabolism in host oral epithelial cells through regulation of the oral microenvironment by improving the microbiome composition. Moreover, we preliminary proved that CP@ZS-NDs promote the healing of OM by inhibiting the UDP-galactose-related metabolic pathway and regulating the Integrin α3β1-Fak-Rac1 axis. These findings demonstrate the effectiveness of CP@ZS-NDs in maintaining oral microbiota homeostasis, which is crucial for the treatment of OM and provide new insights for clinical treatment strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.